Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of v antigen of Yersinia pestis by intranasal immunization in microparticles

Jayaprakash Babu Uppada, Arif Azam Khan, Ajaz Ahmad Bhat, Ranjana Deshmukh, Donthamsetty Nageswara Rao

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Capsular F1 and secretory V antigen are the putative vaccine candidates for plague, caused by Yersinia pestis. Contemplating this, we studied the immunogenicity and protective efficacy of collinearly synthesized B- and T-cell epitopes (B-T constructs) of V antigen entrapped in poly (dl-lactide-co- glycolide) microparticles immunized intranasally using single dose immunization schedule in outbred, H-2b and H-2d mice. High antibody levels were observed in terms of IgG, IgA and SIgA peak titers in sera and mucosal washes to different B-T constructs. The constructs ai, bi and fi especially showed high peak antibody titers ranging from 51,200 to 204,000, which were maintained till day 120 post immunization. IgG/IgA Specific activity in sera and washes correlated well with the peak antibody titers. Moreover, all the B-T constructs showed mixed IgG1 and IgG2a/2b response, variable immunoreactivity as well as memory response with V antigen. B-T constructs, viz ai, ak, bi, fi, di and ik showed comparatively high isotype levels. These constructs showed high immunoreactivity, and good recall response with V antigen. Finally, in vivo protective study in BALB/c mice demonstrated the protective efficacy of three B-T constructs (ai, bi and fi) against lethal doses of Yersinia pestis till day 20 post challenge, while construct 'id' showed partial protection.

Original languageEnglish
Pages (from-to)247-256
Number of pages10
JournalMedical Microbiology and Immunology
Volume198
Issue number4
DOIs
Publication statusPublished - 1 Nov 2009
Externally publishedYes

Fingerprint

B-Lymphocyte Epitopes
Yersinia pestis
T-Lymphocyte Epitopes
Humoral Immunity
Immunization
Antigens
Immunoglobulin G
Immunoglobulin A
Antibodies
Plague Vaccine
Immunization Schedule
Polyglactin 910
Secretory Immunoglobulin A
Serum

Keywords

  • B-T construct
  • Intranasal
  • Microparticles
  • Mucosal immunity
  • Plague
  • V antigen

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Microbiology (medical)

Cite this

Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of v antigen of Yersinia pestis by intranasal immunization in microparticles. / Uppada, Jayaprakash Babu; Khan, Arif Azam; Bhat, Ajaz Ahmad; Deshmukh, Ranjana; Rao, Donthamsetty Nageswara.

In: Medical Microbiology and Immunology, Vol. 198, No. 4, 01.11.2009, p. 247-256.

Research output: Contribution to journalArticle

@article{9c8788e5ce11469b9e48c8027a1554c2,
title = "Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of v antigen of Yersinia pestis by intranasal immunization in microparticles",
abstract = "Capsular F1 and secretory V antigen are the putative vaccine candidates for plague, caused by Yersinia pestis. Contemplating this, we studied the immunogenicity and protective efficacy of collinearly synthesized B- and T-cell epitopes (B-T constructs) of V antigen entrapped in poly (dl-lactide-co- glycolide) microparticles immunized intranasally using single dose immunization schedule in outbred, H-2b and H-2d mice. High antibody levels were observed in terms of IgG, IgA and SIgA peak titers in sera and mucosal washes to different B-T constructs. The constructs ai, bi and fi especially showed high peak antibody titers ranging from 51,200 to 204,000, which were maintained till day 120 post immunization. IgG/IgA Specific activity in sera and washes correlated well with the peak antibody titers. Moreover, all the B-T constructs showed mixed IgG1 and IgG2a/2b response, variable immunoreactivity as well as memory response with V antigen. B-T constructs, viz ai, ak, bi, fi, di and ik showed comparatively high isotype levels. These constructs showed high immunoreactivity, and good recall response with V antigen. Finally, in vivo protective study in BALB/c mice demonstrated the protective efficacy of three B-T constructs (ai, bi and fi) against lethal doses of Yersinia pestis till day 20 post challenge, while construct 'id' showed partial protection.",
keywords = "B-T construct, Intranasal, Microparticles, Mucosal immunity, Plague, V antigen",
author = "Uppada, {Jayaprakash Babu} and Khan, {Arif Azam} and Bhat, {Ajaz Ahmad} and Ranjana Deshmukh and Rao, {Donthamsetty Nageswara}",
year = "2009",
month = "11",
day = "1",
doi = "10.1007/s00430-009-0124-7",
language = "English",
volume = "198",
pages = "247--256",
journal = "Medical Microbiology and Immunology",
issn = "0300-8584",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of v antigen of Yersinia pestis by intranasal immunization in microparticles

AU - Uppada, Jayaprakash Babu

AU - Khan, Arif Azam

AU - Bhat, Ajaz Ahmad

AU - Deshmukh, Ranjana

AU - Rao, Donthamsetty Nageswara

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Capsular F1 and secretory V antigen are the putative vaccine candidates for plague, caused by Yersinia pestis. Contemplating this, we studied the immunogenicity and protective efficacy of collinearly synthesized B- and T-cell epitopes (B-T constructs) of V antigen entrapped in poly (dl-lactide-co- glycolide) microparticles immunized intranasally using single dose immunization schedule in outbred, H-2b and H-2d mice. High antibody levels were observed in terms of IgG, IgA and SIgA peak titers in sera and mucosal washes to different B-T constructs. The constructs ai, bi and fi especially showed high peak antibody titers ranging from 51,200 to 204,000, which were maintained till day 120 post immunization. IgG/IgA Specific activity in sera and washes correlated well with the peak antibody titers. Moreover, all the B-T constructs showed mixed IgG1 and IgG2a/2b response, variable immunoreactivity as well as memory response with V antigen. B-T constructs, viz ai, ak, bi, fi, di and ik showed comparatively high isotype levels. These constructs showed high immunoreactivity, and good recall response with V antigen. Finally, in vivo protective study in BALB/c mice demonstrated the protective efficacy of three B-T constructs (ai, bi and fi) against lethal doses of Yersinia pestis till day 20 post challenge, while construct 'id' showed partial protection.

AB - Capsular F1 and secretory V antigen are the putative vaccine candidates for plague, caused by Yersinia pestis. Contemplating this, we studied the immunogenicity and protective efficacy of collinearly synthesized B- and T-cell epitopes (B-T constructs) of V antigen entrapped in poly (dl-lactide-co- glycolide) microparticles immunized intranasally using single dose immunization schedule in outbred, H-2b and H-2d mice. High antibody levels were observed in terms of IgG, IgA and SIgA peak titers in sera and mucosal washes to different B-T constructs. The constructs ai, bi and fi especially showed high peak antibody titers ranging from 51,200 to 204,000, which were maintained till day 120 post immunization. IgG/IgA Specific activity in sera and washes correlated well with the peak antibody titers. Moreover, all the B-T constructs showed mixed IgG1 and IgG2a/2b response, variable immunoreactivity as well as memory response with V antigen. B-T constructs, viz ai, ak, bi, fi, di and ik showed comparatively high isotype levels. These constructs showed high immunoreactivity, and good recall response with V antigen. Finally, in vivo protective study in BALB/c mice demonstrated the protective efficacy of three B-T constructs (ai, bi and fi) against lethal doses of Yersinia pestis till day 20 post challenge, while construct 'id' showed partial protection.

KW - B-T construct

KW - Intranasal

KW - Microparticles

KW - Mucosal immunity

KW - Plague

KW - V antigen

UR - http://www.scopus.com/inward/record.url?scp=70350596217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350596217&partnerID=8YFLogxK

U2 - 10.1007/s00430-009-0124-7

DO - 10.1007/s00430-009-0124-7

M3 - Article

C2 - 19779739

AN - SCOPUS:70350596217

VL - 198

SP - 247

EP - 256

JO - Medical Microbiology and Immunology

JF - Medical Microbiology and Immunology

SN - 0300-8584

IS - 4

ER -